Forecast Period
|
2024-2028
|
Market Size (2028)
|
USD 14.89 billion
|
CAGR (2023-2028)
|
6.45%
|
Fastest Growing Segment
|
Non-Biodegradable Fibre
|
Largest Market
|
Asia Pacific
|
Market
Overview
Global Biomedical Textiles Market is
expected to reach at USD 14.89 billion by 2028 and is anticipated to project
robust growth in the forecast period with a CAGR of 6.45% through 2028. Biomedical
textiles are fibrous textiles designed for use in medical and biological
applications. These textiles play a crucial role in first aid, surgery, and
maintaining a disinfected environment. Their performance relies on their
biocompatibility with living tissue and fluids. Biomedical textiles possess
specific properties such as chemical inertness, sterility, non-allergenicity,
biocompatibility, flexibility, and non-toxicity. They find applications in
various fields including Dentistry, Surgery, Neurology, and Cardiology.
Additionally, biomedical textiles contribute to the production of surgical
sutures, tissue implants, and artificial organs.
Over the past few decades, the
production of medical textiles, their materials, and manufacturing techniques
have undergone significant advancements. Biomedical implants are utilized to
support or replace damaged tissues and organs. These materials play a vital role
in influencing the body's repair process, whether in wound closure through
sutures or in replacement surgeries involving vascular grafts or artificial
ligaments. While transplantation is a natural method to replace a defective
body part, it may not always be feasible due to various reasons. In such cases,
doctors resort to the use of artificial substitutes, also known as
biomaterials, such as fibers. A foreign or synthetic material used to partially
replace a body part is referred to as a prosthesis, with artificial knees and
hips being examples familiar to most.
The key characteristic of biomedical
textiles is their ability to fulfill their intended purpose. For instance,
sutures may require biodegradable textiles, while artificial ligaments are
designed to be permanent and may interact more strongly with blood cells and
surrounding tissue compared to external bandages, which are temporary and only
contact the outer skin tissue. Implantable devices must be biocompatible, and
biocompatibility testing evaluates the response of the host system to medical
textiles. The results of these tests should be considered in conjunction with
the advantages offered by the specific device.
One of the major driving factors for the
biomedical textiles market is the increasing elderly population worldwide.
Age-related physiological changes make older individuals more susceptible to
orthopedic, cardiovascular, spinal, and eye diseases. Many of these conditions
can be effectively treated through surgical techniques, leading to a higher
demand for surgical interventions. According to a report by the Centers for
Disease Control and Prevention (CDC), falls are treated in emergency
departments for approximately 27 million elderly patients in the United States
alone each year. With age, declining cell function reduces the body's ability
to seal and heal wounds, making chronic lesions like pressure ulcers relatively
common among older individuals. Sutures, implants, and wound care products are
often required by the elderly population, further driving the demand for
biomedical textiles as the population continues to age.
The biomedical textiles market also
benefits from the use of advanced materials that are resistant to various
bacteria, fungi, fire, dirt, and water. Developing these substances requires
extensive research and development to provide specialized products that meet
healthcare specifications. Similar to the production of high-quality fabrics,
research and development costs for biomedical textiles are high due to labor,
technology, and associated expenses. Additionally, the production of these
materials necessitates efficient machinery, state-of-the-art technology, and
suitable raw materials.
Moreover, the raw materials used in
antimicrobial biomedical textiles contain significant amounts of fiber
aggregates and antimicrobial agents such as silver, copper, and quaternary
ammonium. The manufacturing process for these textiles is complex and requires
market participants to ensure the production of high-quality fibers. As a result,
the high research and development costs associated with these textiles act as a
restraint on market growth.
Furthermore, the emergence of smart
biomedical textiles has introduced wearable materials that incorporate
semiconductors and sensors into the fabric. These textiles are utilized in
patient clothing to monitor coronary charge, blood pressure, pulse, body
temperature, respiratory rate, humidity, and pH levels, enabling comprehensive
health screening.
As the demand for biomedical textiles
continues to rise, the industry faces the challenge of meeting evolving
healthcare needs by providing innovative and specialized solutions. Extensive
research, development, and investment in advanced technologies and raw
materials are essential for driving the growth and progress of this dynamic
sector.
Key
Market Drivers
Advancements in Medical Textiles
Biomedical textiles are materials
specifically designed to be used in specific biological environments, where
their exceptional performance can lead to significant medical benefits. These
advanced textiles find applications in a wide range of areas, including wound
care, implantable devices, extracorporeal devices, and healthcare and hygiene
products.
Innovation has always been the driving
force behind the biomedical textiles industry. Scientists and manufacturers are
constantly pushing boundaries to develop new materials and technologies that
can revolutionize patient outcomes and enhance the delivery of healthcare
services.
In recent years, we have witnessed
remarkable advancements in medical textiles, particularly with the introduction
of smart or intelligent textiles. These innovative materials are equipped with
sensors and other electronic components that enable them to monitor patients'
health conditions, administer drugs, or even respond to environmental changes.
For instance, groundbreaking research
has led to the development of bandages made from biomedical textiles that
possess the remarkable ability to detect infections and release antibiotics
precisely when needed. Such revolutionary innovations not only enhance patient
care but also alleviate the burden on healthcare professionals.
Moreover, nanotechnology has played a
pivotal role in propelling the field of medical textiles forward. By
manipulating materials at the atomic level, scientists have been able to create
textiles with exceptional properties, such as enhanced strength, improved
biocompatibility, and advanced drug delivery capabilities.
For example, nanofibers are now being
utilized to create scaffolds for tissue engineering, offering newfound hope for
patients who require organ transplants. Simultaneously, nanoparticles are being
incorporated into wound dressings to expedite healing and prevent infections.
Looking ahead, the future of biomedical
textiles appears incredibly promising. As research continues and technology
advances, we can expect to witness even more groundbreaking applications for
these remarkable materials.
The development of biodegradable
biomedical textiles holds the potential to revolutionize the industry by
eliminating the need for surgical removal once their purpose has been
fulfilled. Similarly, the integration of artificial intelligence and machine
learning could pave the way for the creation of "smart" medical
textiles that possess the ability to predict and promptly respond to patients'
needs in real-time.
Download Free Sample Report
Growth in Chronic Ailments
Chronic diseases, such as heart disease,
diabetes, and cancer, are on the rise worldwide. This increase can be
attributed to various factors, including aging populations, sedentary
lifestyles, unhealthy dietary habits, and exposure to environmental pollutants.
As the global population continues to grow and age, the burden of chronic
illnesses is expected to escalate further.
The growing prevalence of chronic
diseases necessitates innovative healthcare solutions that can effectively
manage and treat these conditions. This is where biomedical textiles come into
play. Biomedical textiles, encompassing a wide range of applications including
implantable devices, wound care products, and extracorporeal devices, have
emerged as essential components in the management and treatment of chronic
ailments.
For instance, biomedical textiles are
utilized in the fabrication of artificial arteries, heart valves, and
orthopedic implants, providing critical support and functionality for patients
with various chronic conditions. These advanced materials not only enhance
patient outcomes but also contribute to improving the overall quality of life
for individuals living with chronic diseases.
To meet the growing demand for more
personalized and responsive healthcare solutions, there has been a surge in the
development of smart biomedical textiles. These innovative materials are
embedded with sensors and actuators that can monitor health conditions, deliver
targeted medications, and respond to changes in a patient's condition. This
integration of technology with biomedical textiles offers immense potential for
the management and treatment of chronic diseases, paving the way for more
proactive and efficient healthcare approaches.
Furthermore, the rise in chronic
diseases has also spurred advancements in the field of nanotechnology within
the biomedical textiles industry. Nanofibers and nanoparticles are being
incorporated into these textiles to enhance their properties and capabilities,
such as improved strength, flexibility, and drug delivery efficiency. These
nano-enhanced biomedical textiles provide even more effective solutions for
chronic disease management, enabling precise and targeted interventions.
In conclusion, the global biomedical
textiles market is being driven by the growing prevalence of chronic diseases.
As the burden of these conditions continues to rise, there is an increasing
demand for advanced and innovative solutions like biomedical textiles. These
materials play a crucial role in modern healthcare, offering not only improved
patient outcomes but also the potential for future growth and development. By continually
pushing the boundaries of technology and innovation, biomedical textiles have
the power to revolutionize the way we manage and treat chronic diseases,
ultimately improving the lives of millions of individuals worldwide.
Key
Market Challenges
Growth in Ethical and Environmental
Concerns
Ethical issues in the biomedical
textiles market are multifaceted, encompassing various aspects such as labor
practices and human rights in the supply chain. The textile and clothing
industry, historically, has faced criticism for its association with poor
working conditions and labor rights violations. As consumers, regulators, and
advocacy groups increasingly scrutinize these practices, companies operating in
the biomedical textiles market are under mounting pressure to ensure ethical
standards throughout their operations.
Another significant concern is the
environmental impact of biomedical textiles. The production process for these
materials often requires substantial resources and generates significant waste,
contributing to environmental degradation. Additionally, the lack of
recyclability in many biomedical textiles poses challenges for waste management
once these products reach the end of their lifecycle.
The issue of sustainability is
particularly pressing in the context of fast fashion, where the rapid turnover
of products exacerbates environmental problems. Although the biomedical
textiles market differs from the fashion industry, it also faces similar
expectations to reduce its environmental footprint. Implementing sustainable
practices and exploring innovative solutions are crucial for addressing these
challenges and promoting a more sustainable future in the biomedical textiles
industry.
Key
Market Trends
Incorporation of Nanotechnology and Biomaterials
Nanotechnology has revolutionized the
field of biomedical textiles, opening up new frontiers and pushing the
boundaries of what is possible. By manipulating materials at the molecular
level, nanotechnology enables the creation of textiles with exceptional
properties such as superior strength, durability, and biocompatibility.
Another significant trend in the
biomedical textiles market is the emergence of biomaterials, which hold great
promise for various healthcare applications. These biomaterials, derived from
natural sources, are embedded with nanoparticles and have been extensively
studied for their potential in biomedical applications.
One example of successful integration is
the combination of carbonaceous nanomaterials (CNMs) with biomaterials. This
integration has resulted in a new class of CNMs-integrated biomaterials that
exhibit enhanced properties, paving the way for advanced solutions in critical
areas such as wound care, implantable devices, and tissue engineering.
The integration of nanotechnology and
biomaterials sets the stage for the next generation of biomedical textiles.
These advancements not only drive market growth but also open up exciting
avenues for further research and development, fueling innovation and improving
healthcare outcomes.
However, as the market continues to
evolve, it becomes crucial for manufacturers and researchers to address
potential challenges. Ethical considerations, environmental impact, and
regulatory compliance must be taken into account to ensure sustainable growth
in the biomedical textiles industry.
In conclusion, the integration of
nanotechnology and biomaterials is a key trend shaping the global biomedical
textiles market. This trend, driven by ongoing research and technological
advancements, holds immense potential for the future of healthcare, offering
groundbreaking solutions and improving the lives of countless individuals.
Segmental
Insights
Fabric Type Insights
Based on the category of fabric type,
the Non-Woven Fabric segment emerged as the dominant player in the global
market for Biomedical Textiles in 2022. Non-woven fabric delivers critical
safety properties, such as prevention against infections and diseases, as they
help to fight against cross-contamination and the spread of infection in
medical or surgical environments. Their unique composition and structure make
them highly effective in creating a barrier that hinders the transmission of
harmful pathogens.
In addition, nonwovens are increasingly
being used in the design of smart wound care products, revolutionizing the way
we treat wounds. These advanced non-woven materials offer a range of functions,
including promoting moist wound healing environments, reducing skin adhesion
for painless removal, and controlling vapor transmission to optimize healing
conditions.
The versatility of non-woven fabrics is
evident in their wide range of applications. They are commonly used in surgical
dressings, bandages, and implant applications, providing a sterile and
protective environment for patients. Moreover, the biomedical field has
embraced the use of non-woven fabrics in various forms, such as sheets, tubes,
gowns, face masks, scrub suits, shoe covers, head covers, sponges, wipes, and
plugs. These innovative products have paved the way for improved patient care
and enhanced infection control protocols.
Compared to traditional woven fabrics,
nonwovens offer several advantages that contribute to their increasing adoption
in healthcare applications. They are more adaptable, allowing for customized
designs and tailored solutions that meet specific medical requirements.
Non-woven fabrics are also cost-effective, providing an affordable option
without compromising on safety or quality. Their disposable nature eliminates
the need for complex sterilization processes, saving time and resources.
Moreover, non-woven are highly efficient in their functionality, offering
superior performance and reliability in critical healthcare settings.
As the demand for advanced healthcare
solutions continues to grow, non-woven fabrics remain at the forefront of
innovation, driving the progress in infection prevention and patient care.
Application Insights
The Non-Implantable segment is projected
to experience rapid growth during the forecast period. The use of
non-implantable products plays a crucial role in various aspects of healthcare.
These products serve multiple purposes, including preventing the spread of
infection, absorbing blood or exudates, and promoting healing. With the
increasing number of surgeries and accidents, the demand for biomedical
textiles in non-implantable products is on the rise. These products are applied
externally to the body and do not require direct contact with the skin.
When it comes to non-implantable solid
products, there is a wide range of options available. Bandages, orthopedic
belts, plasters, gauze, wound care dressings, pressure garments, and others are
used to protect against infection, absorb and exude blood and excess fluid, and
facilitate the healing process. The versatility and strength provided by
biomedical textiles have led to their increasing applications in these
non-implantable products.
Furthermore, the growing prevalence of
diabetes and the rise in home healthcare services have contributed to an increased
demand for wound care management products and the use of biomedical textiles.
As the diagnosis of diabetes continues to surge, there is a greater need for
effective wound care solutions, which further highlights the importance of
biomedical textiles in this field.
Overall, the utilization of biomedical
textiles in non-implantable products is instrumental in ensuring better
healthcare outcomes and improving patient well-being.
Download Free Sample Report
Regional
Insights
Asia Pacific emerged as the
dominant player in the Global Biomedical Textiles Market in 2022, holding the
largest market share in terms of value. The increase in chronic wounds and
surgical procedures has contributed to the growth of the market. Moreover, the healthcare
industry in developing countries like India and China has witnessed rapid
expansion, further driving the revenue growth. In 2020, healthcare expenditures
in India and China reached USD 194 billion and USD 1.06 trillion, respectively,
highlighting the significant investment in healthcare. Additionally, the use of
biomedical textiles in various surgical procedures, including orthopedics,
neurovascular, cardiovascular, and general surgery, has been steadily
increasing in this region. This growing adoption of biomedical textiles is
expected to play a crucial role in driving the market's revenue growth.
Recent
Developments
- In September 2022, Royal DSM N.V., a
global science-based company, acquired Prodapv, Brazil's leading animal
nutrition and technology company. This strategic acquisition further
strengthens Royal DSM's position in the animal nutrition market and expands its
portfolio of innovative solutions for sustainable and efficient livestock
production.
- In August 2022, Medtronic plc, a
renowned medical technology company, completed the acquisition of Affera Inc.,
a cutting-edge technology provider specializing in the treatment of cardiac
arrhythmia. This acquisition enhances Medtronic's capabilities in delivering
advanced solutions for patients with heart rhythm disorders, ultimately
improving their quality of life and overall cardiac health.
- On 5 August 2019, Paul Hartmann AG, a
leading provider of medical and healthcare products, announced the acquisition
of Safran Coating, a technology leader in the field of silicone coatings for
healthcare providers. This strategic move enables Paul Hartmann AG to expand
its range of innovative wound care solutions, leveraging the benefits of
silicone technology to enhance patient outcomes and promote better healing.
Key
Market Players
- Swicofil AG
- DSM BV
- Cortland Biomedical
- Poly-Med Incorporated
- Bally Ribbon Mills, Inc.
- Atex Technologies Inc.
- Medline Industries Inc.
- B. Braun Melsungen AG
- Integra Lifesciences
Corporation
- Elkem ASA
By Fibre
Type
|
By Fabric Type
|
By Application
|
By Region
|
- Non-Biodegradable Fibre
- Biodegradable Fibre
|
- Non-Woven
Fabric
- Woven
Fabric
- Others
|
- Non-Implantable
- Surgical Suture
- Others
|
- North America
- Europe
- Asia Pacific
- South America
- Middle East & Africa
|
Report Scope:
In this report, the Global Biomedical Textiles
Market has been segmented into the following categories, in addition to the
industry trends which have also been detailed below:
- Biomedical Textiles Market, By Fibre Type:
o Non-Biodegradable Fibre
o Biodegradable Fibre
- Biomedical Textiles Market, By Fabric Type:
o Non-Woven Fabric
o Woven Fabric
o Others
- Biomedical Textiles Market, By Application:
o Non-Implantable
o Surgical Suture
o Others
- Biomedical Textiles Market,
By Region:
o North America
§ United States
§ Canada
§ Mexico
o Europe
§ France
§ United Kingdom
§ Italy
§ Germany
§ Spain
o Asia-Pacific
§ China
§ India
§ Japan
§ Australia
§ South Korea
o South America
§ Brazil
§ Argentina
§ Colombia
o Middle East & Africa
§ South Africa
§ Saudi Arabia
§ UAE
§ Kuwait
§ Turkey
§ Egypt
Competitive Landscape
Company Profiles: Detailed analysis of the major companies
present in the Global Biomedical Textiles Market.
Available Customizations:
Global Biomedical Textiles Market report with the
given market data, TechSci Research offers customizations according to a
company's specific needs. The following customization options are available for
the report:
Company Information
- Detailed analysis and
profiling of additional market players (up to five).
Global Biomedical
Textiles Market is an upcoming report to be released soon. If you wish an early
delivery of this report or want to confirm the date of release, please contact
us at [email protected]